Position in CDXS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,344,537
+$174,020 QoQ
Shares Held
824,870
+14.9% QoQ
Ownership
0.907%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CDXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $9,665,390,330 across 365 Biotechnology names. CDXS ranks #234 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in CDXS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,344,537 | 824,870 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,170,517 | 718,109 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $1,767,182 | 724,255 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,094,998 | 448,770 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $831,440 | 309,086 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $2,516,761 | 527,623 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $1,709,827 | 555,139 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,485,736 | 479,270 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $720,056 | 206,320 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $777,594 | 254,949 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $731,280 | 386,921 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $849,046 | 303,231 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $1,210,614 | 292,419 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $6,598,890 | 1,416,071 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $7,812 | 1,289,129 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $17,641 | 1,686,514 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $30,375,177 | 1,473,093 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $37,412,334 | 1,196,429 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $28,932,230 | 1,243,862 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $28,031,709 | 1,237,057 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $27,361,880 | 1,195,364 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $32,284,343 | 1,478,898 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $15,908,204 | 1,355,043 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $15,434,345 | 1,353,890 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $15,626,498 | 1,400,224 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||